Categories
- Global News Feed
- Uncategorized
- Alabama Stem Cells
- Alaska Stem Cells
- Arkansas Stem Cells
- Arizona Stem Cells
- California Stem Cells
- Colorado Stem Cells
- Connecticut Stem Cells
- Delaware Stem Cells
- Florida Stem Cells
- Georgia Stem Cells
- Hawaii Stem Cells
- Idaho Stem Cells
- Illinois Stem Cells
- Indiana Stem Cells
- Iowa Stem Cells
- Kansas Stem Cells
- Kentucky Stem Cells
- Louisiana Stem Cells
- Maine Stem Cells
- Maryland Stem Cells
- Massachusetts Stem Cells
- Michigan Stem Cells
- Minnesota Stem Cells
- Mississippi Stem Cells
- Missouri Stem Cells
- Montana Stem Cells
- Nebraska Stem Cells
- New Hampshire Stem Cells
- New Jersey Stem Cells
- New Mexico Stem Cells
- New York Stem Cells
- Nevada Stem Cells
- North Carolina Stem Cells
- North Dakota Stem Cells
- Oklahoma Stem Cells
- Ohio Stem Cells
- Oregon Stem Cells
- Pennsylvania Stem Cells
- Rhode Island Stem Cells
- South Carolina Stem Cells
- South Dakota Stem Cells
- Tennessee Stem Cells
- Texas Stem Cells
- Utah Stem Cells
- Vermont Stem Cells
- Virginia Stem Cells
- Washington Stem Cells
- West Virginia Stem Cells
- Wisconsin Stem Cells
- Wyoming Stem Cells
- Biotechnology
- Cell Medicine
- Cell Therapy
- Diabetes
- Epigenetics
- Gene therapy
- Genetics
- Genetic Engineering
- Genetic medicine
- HCG Diet
- Hormone Replacement Therapy
- Human Genetics
- Integrative Medicine
- Molecular Genetics
- Molecular Medicine
- Nano medicine
- Preventative Medicine
- Regenerative Medicine
- Stem Cells
- Stell Cell Genetics
- Stem Cell Research
- Stem Cell Treatments
- Stem Cell Therapy
- Stem Cell Videos
- Testosterone Replacement Therapy
- Testosterone Shots
- Transhumanism
- Transhumanist
Archives
Recommended Sites
Monthly Archives: June 2022
Accutar Biotechnology Announces Fast Track Designation Granted by FDA to AC0176 for the Treatment of Metastatic Castration-Resistant Prostate Cancer -…
Posted: June 4, 2022 at 2:07 am
BROOKLYN, N.Y.--(BUSINESS WIRE)--Accutar Biotechnology, Inc., a clinical stage biotechnology company focusing on artificial intelligence (AI)-enabled drug discovery, today announced that the U.S. Food and Drug Administration (FDA) has granted Fast Track designation to AC0176 for the treatment of patients with metastatic castration resistant prostate cancer (mCRPC) with disease progression on or after treatment with androgen receptor signaling inhibitors. AC0176 is an orally bioavailable, chimeric degrader molecule targeting the androgen receptor (AR). AC0176 is currently being evaluated in a Phase 1 clinical trial to assess the safety, tolerability, pharmacokinetics, and preliminary anti-tumor activity in patients with mCRPC.
mCRPC is a devastating cancer for men marked by high recurrence rate and poor survival. Receiving Fast Track designation from the FDA highlights the high unmet medical need for mCRPC and acknowledges the potential of AC0176 as a novel treatment for this patient population, said Jie Fan, Ph.D., Chief Executive Officer of Accutar Biotechnology, Inc. "AC0176 was designed to potently degrade both AR wildtype and prevalent AR mutations which confer drug resistance to current AR signaling inhibitors. We look forward to continued interaction with FDA as we quickly advance the development of this potentially promising treatment option for patients in need.
About Metastatic Castration-Resistant Prostate Cancer (mCRPC)
Prostate cancer (PC) is the second most commonly diagnosed cancer among men worldwide, and the first among men in the United States. mCRPC is a lethal diagnosis, and more effective therapeutic approaches are urgently needed for patients, particularly those who progressed on AR signaling inhibitors. AR-reactivating mechanisms conferring resistance to AR signaling inhibitors include, AR amplification and overexpression, AR point mutations, AR splicing variants, intra-tumoral androgen synthesis, promiscuous AR activation by other factors, etc.
About AC0176
AC0176 is an investigational orally bioavailable, chimeric degrader of AR for the potential treatment of prostate cancers. In preclinical studies, AC0176 demonstrated potent and selective AR protein degradation, favorable pharmacological properties, as well as promising anti-tumor activity in animal models. AC0176 was designed to have broad coverage of AR wildtype and prevalent AR mutations, including but not limited to L702H, T878A, H875Y, W742C. AC0176 is being evaluated in a Phase 1 clinical trial, and information on the study can be found on http://www.clinicaltrials.gov (NCT05241613).
About Accutar Biotechnology, Inc.
Accutar is a clinical stage biotech company focused on AI-enabled drug discovery, and its application to the discovery and development of clinically differentiated medicines.
Be transformative. For patients.
To learn more about Accutar, please visit us at http://www.accutarbio.com.
Posted in Biotechnology
Comments Off on Accutar Biotechnology Announces Fast Track Designation Granted by FDA to AC0176 for the Treatment of Metastatic Castration-Resistant Prostate Cancer -…
G7 heads call for decarbonisation of industry – European Biotechnology News
Posted: June 4, 2022 at 2:07 am
G7 Climate, Energy and Environment Ministers have announced a wide range of actions to tackle the triple global crisis of climate change, biodiversity loss and pollution".
The G7 ministers underlined the importance of efforts to improve energy efficiency, the need for increased investment in renewable energy, tracking of methane emissions. They also highlighted that it will be important to reduce the EUs reliance on Russian natural gas and oil. In their final communiqu they devoted particular attention the Internnational Energys (IEA) recent report on "Achieving Net Zero Heavy Industry Sectors in G7 Members", which was produced at the request of Germanys G7 Presidency. The report lays out a series of recommendations for G7 economies to advance the transition towards near zero emission steel and cement production as well as in the energy sector.
IEA Executive Director Fatih Birol stressed that the world does not need to choose between the energy crisis and the climate crisis. We can solve both of them with the right investment. Dr Birol urged decision makers not to lock in our future by using the current situation as an excuse to justify investments in large, long-term fossil fuel projects that are inconsistent with efforts to reduce global emissions to net zero.
However, neither the G7 ministers nor Fatih mentioned the biotech "drop-in" solutions that already exist or are about to be launched. These could help reduce growing CO2 emissions immediately while reducing dependence on Russian gas and oil. For example, U.S. biotech firm Lanzatech Inc has established a microbial production platform that can produce chemicals and fuels such as biobutanol with identical energy content to gasoline while consuming and sequestering atmospheric carbon dioxide. On an industrial scale, the company is already producing bioethanol as an admixture for aviation fuel from the exhaust gases of Chinese steelworks in cooperation with Shell and Vattenfall. Biobutanol coming to market next year will have the same energy density as gasoline and could help neutralize CO2 emissions from both the transportation and energy sectors at current levels, if broadly applied.
In addition, Austria's Krajete GmbH has been marketing for a decade a microbial process that produces biomethane on an industrial scale from carbon dioxide emissions and hydrogen, which can be injected into the natural gas grid and could dramatically reduce dependence on Russian gas imports.
In the construction sector, U.S. company Biomanson is commercialising a microbial production process for bioconcrete that binds atmospheric CO2 instead of emitting it. Its stated goal is to cut a quarter of the global CO2 emissions by the construction industry by 2030.
In the food and feed sector, companies such as Deepbranch (UK), Solar Foods (Finland) or Austria's Arkeon Biotechnologies have developed technologies to produce amino acids and proteins from CO2 and H2 that can help drastically curb high-emission factory farming by producing meat alternatives that are land- and commodity-price neutral.
What the processes of industrial biotechnology, so far largely ignored by the EU Commission in favour of agricultural solutions, are capable of achieving will be presented at the Industria Biotec event in Berlin on 7 October. Some of this can be read in European Biotechnology.According to a report published today by the European Court of Auditors, the EU has failed to meet its self-imposed target of spending at least 20% of its money on climate action between 2014 and 2020. while the European Commission claimed the EU spent 216bn on climate action during the period, meeting the 20% target, the auditors found that the reported spending was not always climate-relevant and that the total amount of climate change spending was overstated by at least 72bn. They also expressed concern that the Commission's figures could also be unreliable for the period 2021-2027, when the EU's climate change spending target will be even higher - at 30%. This shows that tackling the climate crisis is not as high on the political agenda as stated publicly.
According to leading climate scientists, the facts have been on the table for 50 years. They cannot explain policy inaction and point to the need for immediate action to limit global warming to 2C above pre-industrial levels
Visit link:
G7 heads call for decarbonisation of industry - European Biotechnology News
Posted in Biotechnology
Comments Off on G7 heads call for decarbonisation of industry – European Biotechnology News
Biotechnology Reagents Market Report: Exponential Growth by Market Size, Share, Trends and Analysis to 2028 The Greater Binghamton Business Journal -…
Posted: June 4, 2022 at 2:07 am
The quality of Global Biotechnology Reagents Market market research report is at par which gains customer confidence and trust. This market report directs business in right direction by giving insights about products, market, customers, competitors and marketing strategy at right time. Hence it acts as a backbone to the business. This market report helps to develop a successful marketing strategy for the business. The business report is very helpful to all sizes of business which makes it simpler to take informed decisions in providing the different aspect of HEALTHCARE industry. The worldwide Global Biotechnology Reagents Market market report contains all the company profiles of the major players and brands.
Download Sample Report @ https://www.databridgemarketresearch.com/request-a-sample/?dbmr=global-biotechnology-reagents-market&kb
The Global Biotechnology Reagents Market market report also indicates a narrowed decisive summary of the market. Along with this, multiple factors which have affected the advancement and improvement in a positive as well as negative manner are also studied in the report. On the contrary, the various factors which will be acting as the opportunities for the development and growth of the Global Biotechnology Reagents Market market in the forecasted period are also mentioned.
A combination of best industry insight, practical solutions, talent solutions and latest technology has been used to structure an excellent Global Biotechnology Reagents Market market report. Thoroughly analysed market segmentation aspect provides a clear idea about the product consumption based on several factors ranging from type, application, deployment model, end user to geographical region. Moreover, drivers and restraints of the market assessed in this wide ranging report makes aware about how the product is getting utilized in the recent market environment and also provide estimations about the future usage. The proper utilization of established statistical tools and coherent models for analysis and forecasting of market data makes Global Biotechnology Reagents Market marketing report outperforming.
Top Keyplayers in Global Biotechnology Reagents Market Report:
Abbott, Agilent Technologies Inc., Danaher, BD, Bio-Rad Laboratories Inc., General Electric, bioMrieux SA, LONZA, F. Hoffmann-La Roche Ltd., Thermo Fisher Scientific Inc., Hoefer, Inc., Meridian Bioscience, Inc., PerkinElmer Inc., Merck KGaA, Promega Corporation, Quality Biological, Siemens AG, Bio-Techne, TAKARA HOLDINGS INC., Sysmex Corporation, Tosoh Corporation, WATERS, W. R. Grace & Co.-Conn., Ortho Clinical Diagnostics, Olympus Corporation and Fitzgerald Industries International
Scope:
Feel Free To Ask Question Before Purchasing The Report @ https://www.databridgemarketresearch.com/inquire-before-buying/?dbmr=global-biotechnology-reagents-market&kb
Regional Analysis
U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.
Request for TOC @ https://www.databridgemarketresearch.com/toc/?dbmr=global-biotechnology-reagents-market&kb
An excellent Global Biotechnology Reagents Market market research report has several benefits which can be projected to wide-ranging aspects of HEALTHCARE industry. It helps to draw target audiences for the clients before launching any advertising campaign. With the market report, it becomes easy to collect industry information more quickly. Moreover, this industry analysis report also solves the purpose of validating the information that has been gathered through internal or primary research. With the finest Global Biotechnology Reagents Market market report, it becomes possible to achieve holistic view of the market effectively and then also benchmark all the companies in the HEALTHCARE industry.
Highlights of TOC:
Chapter 1: Market overview
Chapter 2: Global Induction Global Biotechnology Reagents Market market analysis
Chapter 3: Regional analysis of the Induction Global Biotechnology Reagents Market industry
Chapter 4: Market segmentation based on types and applications
Chapter 5: Revenue analysis based on types and applications
Chapter 6: Market share
Chapter 7: Competitive Landscape
Chapter 8: Drivers, Restraints, Challenges, and Opportunities
Chapter 9: Gross Margin and Price Analysis
Goals and objectives of the Global Biotechnology Reagents Market Market Study
Understanding the opportunities and progress of Global Biotechnology Reagents Market Global Biotechnology Reagents Market market highlights, as well as key regions and countries involved in market growth.
Study the different segments of the Global Biotechnology Reagents Market market and the dynamics of Global Biotechnology Reagents Market in the market.
Categorize Global Biotechnology Reagents Market segments with increasing growth potential and evaluate the futuristic segment market
To analyze the most important trends related to the different segments that help to decipher and convince the Global Biotechnology Reagents Market market.
To verify region-specific growth and development in the Global Biotechnology Reagents Market market.
Understand the key stakeholders in the Global Biotechnology Reagents Market market and the value of the competitive image of the Global Biotechnology Reagents Market market leaders.
To study key plans, initiatives and strategies for the development of the Global Biotechnology Reagents Market market.
Access Full Report @ https://www.databridgemarketresearch.com/reports/global-biotechnology-reagents-market?kb
How DBMR is different than other Market Research Providers:
The inception of DBMR has been backed by providing clients with a holistic view of market conditions and future possibilities/opportunities to reap maximum profits out of their businesses and assist in decision making. Our team of in-house analysts and consultants works tirelessly to understand your needs and suggest the best possible solutions to fulfill your research requirements.
Related Reports:
https://www.databridgemarketresearch.com/reports/global-hypercholesterolemia-treatment-market
https://www.databridgemarketresearch.com/reports/global-botulism-market
About Data Bridge Market Research:
Data Bridge Market Research set forth itself as an unconventional and neoteric Market research and consulting firm with unparalleled level of resilience and integrated approaches. We are determined to unearth the best market opportunities and foster efficient information for your business to thrive in the market. Data Bridge endeavors to provide appropriate solutions to the complex business challenges and initiates an effortless decision-making process.
Contact:
Data Bridge Market Research
US: +1 888 387 2818
UK: +44 208 089 1725
Hong Kong: +852 8192 7475
Corporatesales@databridgemarketresearch.com
Read the original here:
Biotechnology Reagents Market Report: Exponential Growth by Market Size, Share, Trends and Analysis to 2028 The Greater Binghamton Business Journal -...
Posted in Biotechnology
Comments Off on Biotechnology Reagents Market Report: Exponential Growth by Market Size, Share, Trends and Analysis to 2028 The Greater Binghamton Business Journal -…
Malaysia Pharmaceutical & Biotechnology Environmental Monitoring Market Size, Scope and Forecast | Danaher Corporation, Thermo Fisher Scientific,…
Posted: June 4, 2022 at 2:07 am
New Jersey, United States TheMalaysia Pharmaceutical & Biotechnology Environmental Monitoring Marketreport is the result of extensive and expert research into theMalaysia Pharmaceutical & Biotechnology Environmental Monitoringindustry. TheMalaysia Pharmaceutical & Biotechnology Environmental MonitoringMarketreport explains what the market is all about, the market prognosis, several segmentations, and everything that falls under the markets umbrella. It also looks at major and secondary market drivers, market share, potential sales volume, regional analysis, and the markets key segments. The research also includes key variables that contribute to the markets growth as well as elements that might stifle the markets growth. The professionals at VM Reports applied precise research techniques and other analyses.
PESTLE analysis and SWOT analysis are two of the analyses utilized in theMalaysia Pharmaceutical & Biotechnology Environmental MonitoringMarketresearch, and they shed light on numerous internal and external variables that affect the market in every situation. It also includes a section that identifies strengths, weaknesses, opportunities, and threats, as well as Porters five forces model.
Get Full PDF Sample Copy of Report: (Including Full TOC, List of Tables & Figures, Chart) @https://www.verifiedmarketresearch.com/download-sample/?rid=89880
There is also a section dedicated to significant actors and their plans, such as acquisitions, collaborations, and so on. The material in the Malaysia Pharmaceutical & Biotechnology Environmental Monitoring Market research was gathered mostly via expert opinions, interviews, and surveys. Verified Market Research experts have created a Malaysia Pharmaceutical & Biotechnology Environmental Monitoring Market research that is full of clarity, accuracy, and useful information. The data in the report is quite accurate and reliable, with no duplicates or mistakes.
Key Players Mentioned in the Malaysia Pharmaceutical & Biotechnology Environmental Monitoring Market Research Report:
Danaher Corporation, Thermo Fisher Scientific, Merck Kgaa, Eurofins Sinensis, Lonza, Biomerieux, Vai, Cosasco, Rmoni and Amphenol Corporation
Malaysia Pharmaceutical & Biotechnology Environmental MonitoringMarket Segmentation:
Malaysia Pharmaceutical & Biotechnology Environmental Monitoring Market, By Type
Monitoring Equipment Media Software Microbiology Services
Malaysia Pharmaceutical & Biotechnology Environmental Monitoring Market, By Application
Pharmaceutical Industry Biotechnology Industry Academic & Research Institutes
Inquire for a Discount on this Premium Report@ https://www.verifiedmarketresearch.com/ask-for-discount/?rid=89880
Malaysia Pharmaceutical & Biotechnology Environmental Monitoring Market Report Scope
Key questions answered in the report:
1. Which are the five top players of the Malaysia Pharmaceutical & Biotechnology Environmental Monitoring market?
2. How will the Malaysia Pharmaceutical & Biotechnology Environmental Monitoring market change in the next five years?
3. Which product and application will take a lions share of the Malaysia Pharmaceutical & Biotechnology Environmental Monitoring market?
4. What are the drivers and restraints of the Malaysia Pharmaceutical & Biotechnology Environmental Monitoring market?
5. Which regional market will show the highest growth?
6. What will be the CAGR and size of the Malaysia Pharmaceutical & Biotechnology Environmental Monitoring market throughout the forecast period?
For More Information or Query or Customization Before Buying, Visit @ https://www.verifiedmarketresearch.com/product/malaysia-pharmaceutical-biotechnology-environmental-monitoring-market/
Visualize Malaysia Pharmaceutical & Biotechnology Environmental Monitoring Market using Verified Market Intelligence:-
Verified Market Intelligence is our BI-enabled platform for narrative storytelling of this market. VMI offers in-depth forecasted trends and accurate Insights on over 20,000+ emerging & niche markets, helping you make critical revenue-impacting decisions for a brilliant future.
VMI provides a holistic overview and global competitive landscape with respect to Region, Country, and Segment, and Key players of your market. Present your Market Report & findings with an inbuilt presentation feature saving over 70% of your time and resources for Investor, Sales & Marketing, R&D, and Product Development pitches. VMI enables data delivery In Excel and Interactive PDF formats with over 15+ Key Market Indicators for your market.
Visualize Malaysia Pharmaceutical & Biotechnology Environmental Monitoring Market using VMI @ https://www.verifiedmarketresearch.com/vmintelligence/
About Us: Verified Market Research
Verified Market Research is a leading Global Research and Consulting firm that has been providing advanced analytical research solutions, custom consulting and in-depth data analysis for 10+ years to individuals and companies alike that are looking for accurate, reliable and up to date research data and technical consulting. We offer insights into strategic and growth analyses, Data necessary to achieve corporate goals and help make critical revenue decisions.
Our research studies help our clients make superior data-driven decisions, understand market forecast, capitalize on future opportunities and optimize efficiency by working as their partner to deliver accurate and valuable information. The industries we cover span over a large spectrum including Technology, Chemicals, Manufacturing, Energy, Food and Beverages, Automotive, Robotics, Packaging, Construction, Mining & Gas. Etc.
We, at Verified Market Research, assist in understanding holistic market indicating factors and most current and future market trends. Our analysts, with their high expertise in data gathering and governance, utilize industry techniques to collate and examine data at all stages. They are trained to combine modern data collection techniques, superior research methodology, subject expertise and years of collective experience to produce informative and accurate research.
Having serviced over 5000+ clients, we have provided reliable market research services to more than 100 Global Fortune 500 companies such as Amazon, Dell, IBM, Shell, Exxon Mobil, General Electric, Siemens, Microsoft, Sony and Hitachi. We have co-consulted with some of the worlds leading consulting firms like McKinsey & Company, Boston Consulting Group, Bain and Company for custom research and consulting projects for businesses worldwide.
Contact us:
Mr. Edwyne Fernandes
Verified Market Research
US: +1 (650)-781-4080UK: +44 (753)-715-0008APAC: +61 (488)-85-9400US Toll-Free: +1 (800)-782-1768
Email: sales@verifiedmarketresearch.com
Website:- https://www.verifiedmarketresearch.com/
Posted in Biotechnology
Comments Off on Malaysia Pharmaceutical & Biotechnology Environmental Monitoring Market Size, Scope and Forecast | Danaher Corporation, Thermo Fisher Scientific,…
Media, Sera and Reagents in Biotechnology market 2022-2028 Increase in Demand, biggest innovation and Expected to Boost Growth ManufactureLink -…
Posted: June 4, 2022 at 2:07 am
The Global Media, Sera and Reagents in Biotechnology Market research report provides systematic information and powerful insights into the potential size, market share, industrys growth prospects, scope, and challenges. The report evaluates the CAGR, value, volume, sales, revenue, and dynamics of the market during the forecast period of 2022-2028. This report focuses on Media, Sera and Reagents in Biotechnology market growth, current market trends, key driving factors, and overall market prospects. The industry report includes the sales figures, market growth rate, production, capacity, and gross profit margin of each player based on the regional and global market position.
Request Sample Report @ https://www.marketreportsinsights.com/sample/136508
The market overview included in this report provides information from a wide range of resources like government organizations, established companies, trade and industry associations, industry brokers and other such regulatory and non-regulatory bodies. The data acquired from these organizations authenticate the Media, Sera and Reagents in Biotechnology research report, thereby aiding the clients in better decision making. Additionally, the data provided in this report offers a contemporary understanding of the market dynamics.
Media, Sera and Reagents in Biotechnology Market 2022-2028 Research Report is a professional and in-depth study on the current state of the Media, Sera and Reagents in Biotechnology industry. It provides key analysis on the market status of the Media, Sera and Reagents in Biotechnology manufacturers with best facts and figures, meaning, definition, SWOT analysis, expert opinions and the latest developments across the globe. The Report also calculate the market size, Media, Sera and Reagents in Biotechnology Sales, Price, Revenue, Gross Margin and Market Share, cost structure and growth rate. The report considers the revenue generated from the sales of This Report and technologies by various application segments and Browse Market data Tables and Figures.
The leading players are focusing mainly on technological advancements in order to improve efficiency. The long-term development patterns for this market can be captured by continuing the ongoing process improvements and financial stability to invest in the best strategies.
Top Key players of Media, Sera and Reagents in Biotechnology Market are:Athena Environmental Science, Inc.BectonDickinsonCellGenixGE HealthcareLonzaThermo Fisher Scientific, Inc.
Global Media, Sera and Reagents in Biotechnology Market Scope and Size:The Media, Sera and Reagents in Biotechnology market is declared segment by company, region (country), type, and application. Players, stakeholders, and other participants in the global Media, Sera and Reagents in Biotechnology market will gain the market scope as they use the report as a powerful resource. The segmental analysis focuses on revenue and product by type and application and the forecast period of 2022-2028.
Media, Sera and Reagents in Biotechnology Market Types covered in this report are:MediaSeraReagents
Market Applications covered in this report are:Cancer ResearchVirologyToxicity TestingVaccine ProductionDrug Development
Regional AnalysisNorth America (the United States, Canada, and Mexico)Europe (Germany, France, UK, Russia, and Italy)Asia-Pacific (China, Japan, Korea, India, and Southeast Asia)South America (Brazil, Argentina, Colombia, etc.)The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, and South Africa)
Go For Interesting Discount Here: https://www.marketreportsinsights.com/discount/136508
The Media, Sera and Reagents in Biotechnology market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
The content of the study subjects includes a total of 15 chapters:
Chapter 1, to describe Media, Sera and Reagents in Biotechnology product scope, market overview, market opportunities, market driving force and market risks. Chapter 2, to profile the top manufacturers of Media, Sera and Reagents in Biotechnology, with price, sales, revenue and global market share of Media, Sera and Reagents in Biotechnology in 2020 and 2021. Chapter 3, the Media, Sera and Reagents in Biotechnology competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast. Chapter 4, the Media, Sera and Reagents in Biotechnology breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2016 to 2021. Chapter 5, 6, 7, 8 and 9, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2016 to 2021. Chapter 10 and 11, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2016 to 2021. Chapter 12, Media, Sera and Reagents in Biotechnology market forecast, by regions, type and application, with sales and revenue, from 2022 to 2028. Chapter 13, 14 and 15, to describe Media, Sera and Reagents in Biotechnology sales channel, distributors, customers, research findings and conclusion, appendix and data source.
Key Point of the Media, Sera and Reagents in Biotechnology Market report:
Geographical distribution, company profiling, and various other market segmentation are provided in the report. For better understanding of the global Media, Sera and Reagents in Biotechnology market status, the accurate market valuation which comprises of size, share, and revenue are also covered. Analysis of the competitive dynamic factors better extrapolate the complete market overview What will be the size of the emerging Media, Sera and Reagents in Biotechnology market in 2028? The latest trends, opportunities and challenges, and growth drivers provide better construal of the Media, Sera and Reagents in Biotechnology Market. In-detail industrial analysis, sales study, and production understanding shed more light on the future market growth rate and scope. Report also offers the opportunity for customization as per the customer request.
View Full Report @ https://www.marketreportsinsights.com/industry-forecast/media-sera-and-reagents-in-biotechnology-market-2022-136508
At last, the Media, Sera and Reagents in Biotechnology Market report includes investment come analysis and development trend analysis. The present and future opportunities of the fastest growing international industry segments are coated throughout this report. This report additionally presents product specification, manufacturing method, and product cost structure, and price structure.
Contact Us:[emailprotected]
Posted in Biotechnology
Comments Off on Media, Sera and Reagents in Biotechnology market 2022-2028 Increase in Demand, biggest innovation and Expected to Boost Growth ManufactureLink -…
Biosimulation Market Size, Scope and Forecast | Insilico Biotechnology, INOSIM Software, Evidera, Chemical Computing Group, Certara, Simulations Plus,…
Posted: June 4, 2022 at 2:07 am
New Jersey, United States TheBiosimulation Marketreport is the result of extensive and expert research into theBiosimulationindustry. TheBiosimulationMarketreport explains what the market is all about, the market prognosis, several segmentations, and everything that falls under the markets umbrella. It also looks at major and secondary market drivers, market share, potential sales volume, regional analysis, and the markets key segments. The research also includes key variables that contribute to the markets growth as well as elements that might stifle the markets growth. The professionals at VM Reports applied precise research techniques and other analyses.
PESTLE analysis and SWOT analysis are two of the analyses utilized in theBiosimulationMarketresearch, and they shed light on numerous internal and external variables that affect the market in every situation. It also includes a section that identifies strengths, weaknesses, opportunities, and threats, as well as Porters five forces model.
Get Full PDF Sample Copy of Report: (Including Full TOC, List of Tables & Figures, Chart) @https://www.verifiedmarketresearch.com/download-sample/?rid=2339
There is also a section dedicated to significant actors and their plans, such as acquisitions, collaborations, and so on. The material in the Biosimulation Market research was gathered mostly via expert opinions, interviews, and surveys. Verified Market Research experts have created a Biosimulation Market research that is full of clarity, accuracy, and useful information. The data in the report is quite accurate and reliable, with no duplicates or mistakes.
Key Players Mentioned in the Biosimulation Market Research Report:
Insilico Biotechnology, INOSIM Software, Evidera, Chemical Computing Group, Certara, Simulations Plus, ACD/Labs, Dassault Systmes, Nuventra Pharma, Genedata. Company.
BiosimulationMarket Segmentation:
Bio Simulation Market, By Product
Software Services
Bio Simulation Market, By Application
Drug Development Drug Discovery Others
Bio Simulation Market, By End-User
Pharmaceutical and Biotechnology Companies Research Institutes Contract Research Organizations Regulatory Authorities Other
Inquire for a Discount on this Premium Report@ https://www.verifiedmarketresearch.com/ask-for-discount/?rid=2339
Biosimulation Market Report Scope
Key questions answered in the report:
1. Which are the five top players of the Biosimulation market?
2. How will the Biosimulation market change in the next five years?
3. Which product and application will take a lions share of the Biosimulation market?
4. What are the drivers and restraints of the Biosimulation market?
5. Which regional market will show the highest growth?
6. What will be the CAGR and size of the Biosimulation market throughout the forecast period?
For More Information or Query or Customization Before Buying, Visit @ https://www.verifiedmarketresearch.com/product/global-bio-simulation-market-size-and-forecast-to-2025/
Visualize Biosimulation Market using Verified Market Intelligence:-
Verified Market Intelligence is our BI-enabled platform for narrative storytelling of this market. VMI offers in-depth forecasted trends and accurate Insights on over 20,000+ emerging & niche markets, helping you make critical revenue-impacting decisions for a brilliant future.
VMI provides a holistic overview and global competitive landscape with respect to Region, Country, and Segment, and Key players of your market. Present your Market Report & findings with an inbuilt presentation feature saving over 70% of your time and resources for Investor, Sales & Marketing, R&D, and Product Development pitches. VMI enables data delivery In Excel and Interactive PDF formats with over 15+ Key Market Indicators for your market.
Visualize Biosimulation Market using VMI @ https://www.verifiedmarketresearch.com/vmintelligence/
About Us: Verified Market Research
Verified Market Research is a leading Global Research and Consulting firm that has been providing advanced analytical research solutions, custom consulting and in-depth data analysis for 10+ years to individuals and companies alike that are looking for accurate, reliable and up to date research data and technical consulting. We offer insights into strategic and growth analyses, Data necessary to achieve corporate goals and help make critical revenue decisions.
Our research studies help our clients make superior data-driven decisions, understand market forecast, capitalize on future opportunities and optimize efficiency by working as their partner to deliver accurate and valuable information. The industries we cover span over a large spectrum including Technology, Chemicals, Manufacturing, Energy, Food and Beverages, Automotive, Robotics, Packaging, Construction, Mining & Gas. Etc.
We, at Verified Market Research, assist in understanding holistic market indicating factors and most current and future market trends. Our analysts, with their high expertise in data gathering and governance, utilize industry techniques to collate and examine data at all stages. They are trained to combine modern data collection techniques, superior research methodology, subject expertise and years of collective experience to produce informative and accurate research.
Having serviced over 5000+ clients, we have provided reliable market research services to more than 100 Global Fortune 500 companies such as Amazon, Dell, IBM, Shell, Exxon Mobil, General Electric, Siemens, Microsoft, Sony and Hitachi. We have co-consulted with some of the worlds leading consulting firms like McKinsey & Company, Boston Consulting Group, Bain and Company for custom research and consulting projects for businesses worldwide.
Contact us:
Mr. Edwyne Fernandes
Verified Market Research
US: +1 (650)-781-4080UK: +44 (753)-715-0008APAC: +61 (488)-85-9400US Toll-Free: +1 (800)-782-1768
Email: sales@verifiedmarketresearch.com
Website:- https://www.verifiedmarketresearch.com/
View original post here:
Biosimulation Market Size, Scope and Forecast | Insilico Biotechnology, INOSIM Software, Evidera, Chemical Computing Group, Certara, Simulations Plus,...
Posted in Biotechnology
Comments Off on Biosimulation Market Size, Scope and Forecast | Insilico Biotechnology, INOSIM Software, Evidera, Chemical Computing Group, Certara, Simulations Plus,…
Canthaxanthin Market Size, Scope and Forecast | Novepha Company, Guangzhou Wisdom Biotechnology, DSM, BASF, Novus International, Zipont Chem Tech,…
Posted: June 4, 2022 at 2:07 am
New Jersey, United States TheCanthaxanthin Marketreport is the result of extensive and expert research into theCanthaxanthinindustry. TheCanthaxanthinMarketreport explains what the market is all about, the market prognosis, several segmentations, and everything that falls under the markets umbrella. It also looks at major and secondary market drivers, market share, potential sales volume, regional analysis, and the markets key segments. The research also includes key variables that contribute to the markets growth as well as elements that might stifle the markets growth. The professionals at VM Reports applied precise research techniques and other analyses.
PESTLE analysis and SWOT analysis are two of the analyses utilized in theCanthaxanthinMarketresearch, and they shed light on numerous internal and external variables that affect the market in every situation. It also includes a section that identifies strengths, weaknesses, opportunities, and threats, as well as Porters five forces model.
Get Full PDF Sample Copy of Report: (Including Full TOC, List of Tables & Figures, Chart) @https://www.verifiedmarketresearch.com/download-sample/?rid=38503
There is also a section dedicated to significant actors and their plans, such as acquisitions, collaborations, and so on. The material in the Canthaxanthin Market research was gathered mostly via expert opinions, interviews, and surveys. Verified Market Research experts have created a Canthaxanthin Market research that is full of clarity, accuracy, and useful information. The data in the report is quite accurate and reliable, with no duplicates or mistakes.
Key Players Mentioned in the Canthaxanthin Market Research Report:
Novepha Company, Guangzhou Wisdom Biotechnology, DSM, BASF, Novus International, Zipont Chem Tech, Wellgreen Technology Company Limited, Parchem.
CanthaxanthinMarket Segmentation:
Canthaxanthin Market, By Source
Natural Synthetic
Canthaxanthin Market, By Application
Food Additive Feed Additive Cosmetics and Personal Care
Inquire for a Discount on this Premium Report@ https://www.verifiedmarketresearch.com/ask-for-discount/?rid=38503
Canthaxanthin Market Report Scope
Key questions answered in the report:
1. Which are the five top players of the Canthaxanthin market?
2. How will the Canthaxanthin market change in the next five years?
3. Which product and application will take a lions share of the Canthaxanthin market?
4. What are the drivers and restraints of the Canthaxanthin market?
5. Which regional market will show the highest growth?
6. What will be the CAGR and size of the Canthaxanthin market throughout the forecast period?
For More Information or Query or Customization Before Buying, Visit @ https://www.verifiedmarketresearch.com/product/canthaxanthin-market/
Visualize Canthaxanthin Market using Verified Market Intelligence:-
Verified Market Intelligence is our BI-enabled platform for narrative storytelling of this market. VMI offers in-depth forecasted trends and accurate Insights on over 20,000+ emerging & niche markets, helping you make critical revenue-impacting decisions for a brilliant future.
VMI provides a holistic overview and global competitive landscape with respect to Region, Country, and Segment, and Key players of your market. Present your Market Report & findings with an inbuilt presentation feature saving over 70% of your time and resources for Investor, Sales & Marketing, R&D, and Product Development pitches. VMI enables data delivery In Excel and Interactive PDF formats with over 15+ Key Market Indicators for your market.
Visualize Canthaxanthin Market using VMI @ https://www.verifiedmarketresearch.com/vmintelligence/
About Us: Verified Market Research
Verified Market Research is a leading Global Research and Consulting firm that has been providing advanced analytical research solutions, custom consulting and in-depth data analysis for 10+ years to individuals and companies alike that are looking for accurate, reliable and up to date research data and technical consulting. We offer insights into strategic and growth analyses, Data necessary to achieve corporate goals and help make critical revenue decisions.
Our research studies help our clients make superior data-driven decisions, understand market forecast, capitalize on future opportunities and optimize efficiency by working as their partner to deliver accurate and valuable information. The industries we cover span over a large spectrum including Technology, Chemicals, Manufacturing, Energy, Food and Beverages, Automotive, Robotics, Packaging, Construction, Mining & Gas. Etc.
We, at Verified Market Research, assist in understanding holistic market indicating factors and most current and future market trends. Our analysts, with their high expertise in data gathering and governance, utilize industry techniques to collate and examine data at all stages. They are trained to combine modern data collection techniques, superior research methodology, subject expertise and years of collective experience to produce informative and accurate research.
Having serviced over 5000+ clients, we have provided reliable market research services to more than 100 Global Fortune 500 companies such as Amazon, Dell, IBM, Shell, Exxon Mobil, General Electric, Siemens, Microsoft, Sony and Hitachi. We have co-consulted with some of the worlds leading consulting firms like McKinsey & Company, Boston Consulting Group, Bain and Company for custom research and consulting projects for businesses worldwide.
Contact us:
Mr. Edwyne Fernandes
Verified Market Research
US: +1 (650)-781-4080UK: +44 (753)-715-0008APAC: +61 (488)-85-9400US Toll-Free: +1 (800)-782-1768
Email: sales@verifiedmarketresearch.com
Website:- https://www.verifiedmarketresearch.com/
Continue reading here:
Canthaxanthin Market Size, Scope and Forecast | Novepha Company, Guangzhou Wisdom Biotechnology, DSM, BASF, Novus International, Zipont Chem Tech,...
Posted in Biotechnology
Comments Off on Canthaxanthin Market Size, Scope and Forecast | Novepha Company, Guangzhou Wisdom Biotechnology, DSM, BASF, Novus International, Zipont Chem Tech,…
Simpson Healthcare AWARDED ISO/IEC 27001:2013 & ISO/IEC 27701:2019 CERTIFICATION – PR Newswire
Posted: June 4, 2022 at 2:07 am
OLD LYME, Conn., June 2, 2022 /PRNewswire/ -- Simpson Healthcare, a leading scientific agency providing the pharmaceutical, biotechnology, medical diagnostic and device industries with a wide range of services in support of overall marketing strategies, announced today that it has successfully completed the ISO/IEC 27001 certification and its privacy information management extension ISO/IEC 27701.
Scott Algiere, Chief Executive Officer of Simpson Healthcare, commented, "ISO 27001 and ISO 27701 are globally renowned and trusted industry standards. This is an achievement for Simpson Healthcare and demonstrates our continued commitment to ensure security and privacy". This provides independent, third-party validation that we have the appropriate controls in place to mitigate risks related to the services we provide to our customers and is key to our customers upholding their own regulatory obligations. Abdullah Amin, SVP Engineering + IT Security, commented, "These certifications highlight our commitment to data privacy and information security. Our customers know that their information is secure and processed appropriately by maintaining security and compliance".
About ISO/IEC 27001
For ISO/IEC 27001 certification, the scope of Simpson Healthcare information security management system (ISMS) includes people, processes, and technology for creating and supporting their products and services. The report provides assurance to customers that Simpson Healthcare adheres to these stringent, internationally recognized security standards.
ISO/IEC 27001:2013 is one of the most widely recognized and internationally accepted information security standards, detailing best practices for the management of information security and privacy. It identifies requirements for a comprehensive Information Security Management System (ISMS) and establishes quality standards used to measure an organization's IT security controls and processes for handling and managing data.
About ISO/IEC 27701
For ISO/IEC 27701 certification, the scope of Simpson Healthcare privacy information management system (PIMS) includes alignment and incorporation of privacy best practices into people, processes, and technology for protection and management of personally identifiable information (PII).
ISO/IEC 27701:2019 is built to complement the widely-used ISO/IEC 27001 standard for information security management. It specifies requirements and provides guidance for a Privacy Information Management System (PIMS). ISO/IEC 27701 accomplishes the security and privacy integration through a framework for managing personal data that can be used by both data controllers and data processors, a key distinction for General Data Protection Regulation (GDPR) compliance.
A-LIGN, an independent and accredited third-party CPA firm, completed the assessment of Simpson Healthcare' systems and successfully validated that its controls meet the standards required for ISO/IEC 27001 certification as well as ISO/IEC 27701 extension.
About Simpson Healthcare
Simpson Healthcare is an established scientific agency that provides the pharmaceutical, biotechnology, medical diagnostic and device industries with a wide range of services in support of overall marketing strategies. The products and services provided enhance a company's value for the benefit of the stakeholders, while simultaneously disseminating new biomedical knowledge for the benefit of healthcare providers and their patients.
Simpson's high-quality, creative, strategic solutions are delivered with unparalleled customer service, and include brand strategy, KOL development, advisory boards, speaker bureaus, live/virtual speaker training, content development, interactive patient case videos, sales force training, and community live events.
Contact: Abdullah Amin, SVP Engineering + IT Security [emailprotected]
SOURCE Simpson Healthcare
Excerpt from:
Simpson Healthcare AWARDED ISO/IEC 27001:2013 & ISO/IEC 27701:2019 CERTIFICATION - PR Newswire
Posted in Biotechnology
Comments Off on Simpson Healthcare AWARDED ISO/IEC 27001:2013 & ISO/IEC 27701:2019 CERTIFICATION – PR Newswire
Maine health care workers to appeal order to disclose their names in vaccine mandate lawsuit – Lewiston Sun Journal
Posted: June 4, 2022 at 2:04 am
Nine plaintiffs who anonymously sued Gov. Janet Mills over a COVID-19 mandate for health care workers will appeal a U.S. District Court judges decision requiring them to disclose their names by June 7.
The group filed its complaint in federal court last August, before the vaccine mandate for employees of designated Maine health care facilities went into effect Oct. 29.
Using pseudonyms, the health care workers argued that it was their religious right to refuse the vaccine overtheir belief that fetal stem cells from abortions were used to develop it. The state mandate does not allow for religious exemptions.
The Portland Press Herald, Kennebec Journal, Morning Sentinel and Sun Journal filed a motion in November challenging the groups right to file the complaint anonymously.
In his 13-page ruling Tuesday, Chief U.S. District Court Judge Jon D. Levy said he at first allowed the group to withhold their names because they argued they were afraid of the public passions concerning mandatory COVID-19 vaccinations, and that they were at a heightened risk of severe social stigma and worse if their identities were revealed.
In the final analysis, however, there is a near total absence of proof that their expressed fears are objectively reasonable, Levy wrote Tuesday. The Plaintiffs privacy interests have not been shown to outweigh the public interest associated with the presumption of openness that applies to civil proceedings.
Attorneys for the unnamed health care workers did not respond to requests Wednesday afternoon to discuss their appeal. They are represented by Maine attorney Steve Whiting, and lawyers from Liberty Counsel, a conservative, religious law firm based in Florida that has participated in several lawsuits against Maine and other states over COVID-19 vaccine mandates and restrictions. Nationally, the firm also has opposed safe and legal access to abortions and same-sex marriage, and the Southern Poverty Law Center has identified the firm as a hate group.
Before filing the notice to appeal, a spokesperson for Liberty Counsel told the Portland Press Herald on Tuesday night that the firm would not speak with reporters about Levys ruling because of the papers involvement in the lawsuit.
In an emailed statement Wednesday, attorney Sigmund Schutz, who represents the newspapers, said he plans to vigorously defend Levys order.
Chief Judge Levys decision vindicates the bedrock principle of the American justice system that courts operate in secret only in exceptional circumstances, Schutz wrote.
Shannon Jankowski, staff attorney for the Reporters Committee for Freedom of the Press, has joined Schutz as co-counsel. Jankowski said Wednesday that this is the only case the committee is involved in related to vaccine mandates, but that there are several court cases around the country in which people using pseudonyms have tried to challenge mandates. Jankowski said hundreds of other people around the country have filed complaints concerning vaccine mandates in their own names.
In Arizona in January, a judge denied a federal employees motion to anonymously sue President Biden over the U.S. governments vaccine mandate. At about the same time in Colorado, a judge agreed to let a group of university employees anonymously challenge their employers mandate.
These plaintiffs are attempting to invalidate a vaccine mandate that applies throughout the state of Maine, Jankowski said of the anonymous plaintiffs in the Maine lawsuit. This is something that has broad-ranging impacts on all citizens of Maine, and the public has the right to know who these plaintiffs are, what role they play in the health care system. Its important information for the public to be able to assess for themselves whats going on in this case.
Levy is still considering the lawsuit against the vaccine mandate. Meanwhile, federal judges have refused to block the mandate, which has been in effect since last Oct. 29. The states major health care providers reported at the time that most workers chose to get the shots and keep their jobs.
Invalid username/password.
Please check your email to confirm and complete your registration.
Use the form below to reset your password. When you've submitted your account email, we will send an email with a reset code.
Previous
Next
See original here:
Maine health care workers to appeal order to disclose their names in vaccine mandate lawsuit - Lewiston Sun Journal
Posted in Arizona Stem Cells
Comments Off on Maine health care workers to appeal order to disclose their names in vaccine mandate lawsuit – Lewiston Sun Journal
No, "Top Gun" isn’t an anti-woke success story, but rather a tribute to aging Tom Cruise and balls – Salon
Posted: June 4, 2022 at 2:04 am
Explaining the success of "Top Gun: Maverick" isn't tough. All that's required is having some inkling of what we the people enjoy. We adore watching Tom Cruise in action flicks, for one thing, proven by his long track record of bankability.
Fast vehicles are high on our list of likes, too. Put Tom Cruise's Navy Captain Pete "Maverick" Mitchell inside a fighter jet, show him exercising his need for speed through challenging terrain, and guess what? People will plunk down money to see that on as large of a screen as possible.
But do you know what Americans really love? Balls. That affair transcends political affiliation and tribalism. The angry red balls in need of scientifically proven medication tend to get the most attention, but let's not count out our frustrated blue balls and the tricky, harder-to-pin-down purple ones. They're out there too, ready to bounce off their couches and into theaters.
Everyone's feeling a little deflated these days, and Cruise and "Top Gun: Maverick" director Joseph Kosinski know this. Who can forget the 1986 originalwhen a 25-year-old Cruise and his co-star Val Kilmer, each in their oiled-up prime, took to the beach to flex and play . . . what was it? Volleyball? Honestly, I wasn't paying much attention to the sport part.
RELATED: The lost meaning of "Top Gun"
This time around there's a female ace pilot in the mix, Lt. Natasha "Phoenix" Trace (Monica Barbaro), and the game is touch football. Cruise's Maverick, their instructor, envisions the game as having a purpose beyond posturing. It's about team building, he explains to his short-tempered boss Vice Admiral Beau "Cyclone" Simpson (Jon Hamm).
Sure enough, the younger guns all learn to pass the ball, defend the ball, and have fun with the ball.
But the audience knows the teamwork exercise isn't the reason the "Top Gun" sequel includes this scene. Its secondary purpose, the one that rings truer, is to remind us yet again that 59-year-old Cruise is still as ripped as his decades-younger co-stars.
Those who can, do. As for those who can't, forget it. Maverick isn't the type.
That takes stones along with, I'm guessing, many hours of physical effort guided by the best personal trainers in the world, a strict diet, and a supplement regimen that may or may not include alien stem cells. Any mortal may follow that plan and still lack the fortitude to show their vintage pecs to the sun.
Not Tom Cruise. Maverick's got it like that. Those who can, do. As for those who can't, forget it. Maverick isn't the type. The younger pilots may be elite, but it's understood that the chiseled veteran is going to run the ball into the end zone.
No wonder the right-wing is lurching to claim the box office record-breaking success of "Top Gun: Maverick" as a tribute, they say, to "anti-wokeness." Several Fox News hosts crowed about this in the days following the movie's release, echoing Breitbart column headlines. Meghan McCain was the last to jump on the wagon with her Wednesday column in that All-American news rag, The Daily Mail. "Hollywood must wake up to the reality that 'go woke, go broke' is real," she wrote.
The Arizona sage went on to praise "Top Gun: Maverick" for having all the qualities of the typical summertime blockbuster. "The movie isn't overly political, it isn't depressing, it isn't focusing on the flaws of the United States of America and why we suck and why our flag and national anthem aren't worth honoring."
Well, duh. Cruise isn't remaking "Born on the Fourth of July." Clearly this movie is not that one.
Besides, none of the three highest-grossing movies of 2022 "Doctor Strange in the Multiverse of Madness," "The Batman" and "Spider-Man: No Way Home" gripes about America's flaws or disrespects the flag. Why on Earth would they?
However, "Top Gun: Maverick" does something those films don't, in that it comforts a demographic that may harbor grave concerns about its impending obsolescence, its waning influence, and declining potency.
In short, this movie validates the viability of old balls of every size and sort, from raisins to apricots.
Paramount's own demographics breakdown backs this up. It indicates that 55% of the opening weekend's audience was over the age of 35. We're talking elder Millennials, Generation Xers, and Boomers many of whom watched the original "Top Gun" back in the '80s and may be feeling the 36 years that have transpired since.
Tom Cruise plays Capt. Pete "Maverick" Mitchell in "Top Gun: Maverick" (Paramount Pictures / Skydance / Jerry Bruckheimer Films)"Top Gun: Maverick" was made for that crowd even as it bridges generational gaps by emphasizing spectacle over any message, and certainly none deeper than, "Look at Tom Cruise, still keepin' it tight."
For emotional flavor it tosses in some father-son healing between Maverick's father figure and his surrogate child Lt. Bradley "Rooster" Bradshaw (Miles Teller), the son of his dead best friend Goose, by way of a "Behind Enemy Lines" fly-by.
But the main hooks are theroaring flight sequences that vibrate the theater's walls, with visuals reminiscent of Death Star's trench in "Star Wars Episode IV: A New Hope," only brought to life by scenes filmed in F/A-18s flown by top pilots.
"Top Gun: Maverick" is a two-hour, 11-minute Cialis ad.
Long before all of that kicks in, though, we see Maverick being cut down to size by Ed Harris' leathery Rear Admiral Chester "Hammer" Cain, who is keen to replace the likes of our hero with drone technology. "The future is coming, and you're not in it," he growls before adding, "The end is inevitable, Maverick. Your kind is headed for extinction!"
Once you understand that part of the equation, you may get why conservatives are desperate to claim this as their movie.
To that portion of the audience, "Top Gun: Maverick" is a two-hour, 11-minute Cialis ad, starring a guy with flexible hips who can still climb a ladder to clean his own roof gutters.
Maverick represents that aging audience's ideal self. He blasts down the road on his All-American Kawasaki motorcycle, refusing to wear a helmet or play by the rules. His motto is, "Don't think, just do." His three-and-a-half decades-long friendship with Iceman, now known as four-star Admiral Tom "Iceman" Kazansky, ensures he'll never suffer any consequences for, say, disobeying orders and destroying a prototype aircraft that's probably worth the equivalent GDP of a small nation.
He teaches the next generation of the world's best fighter pilots to fly a mission that he ends up leading anyway. Because the world needs Maverick. He's that exceptional.
Is this evidence of intentional "anti-wokeness"? Not so fast. Consider that the sequel also introduces the local bar as a gathering place for men and women in uniform that's run by Maverick's love interest Penny Benjamin (Jennifer Connelly), the "Admiral's daughter" Maverick got in trouble with way back when.
Jennifer Connelly plays Penny Benjamin and Tom Cruise plays Capt. Pete "Maverick" Mitchell in "Top Gun: Maverick" (Paramount Pictures / Skydance / Jerry Bruckheimer Films)In the 1986 flick, the first female presence is introduced by an anonymous actor's thigh poking out from under her skirt. In 2022, a woman makes the bar's rules and has the ovaries to get Maverick physically tossed from the place.
"Top Gun: Maverick" evolves with the times in other ways, too. Maverick's inclusive squad includes Barbaro's Phoenix and her Weapon Systems Officer Lt. Robert "Bob" Floyd (Lewis Pullman), the least aggro male in the class, along with Jay Ellis' Lt. Reuben "Payback" Fitch and Danny Ramirez's Lt. Mickey "Fanboy" Garcia.
The candidate class also includes other non-white faces, a step up from the 1986 class, which includes two Black men, only one of whom had any lines . . . and was passed over for the final mission so Maverick could fly with a WSO from his old squad.
This doesn't change what "Top Gun" or "Top Gun: Maverick" are at their core. The franchise was born in the middle of the Reagan era. Then, and now, it is a militaristic fantasy upholding the concept of white American exceptionalism. Even now, in Maverick's inclusive team, non-white characters are flanking him, rooting for him, but none rise high enough to steal his spotlight.
Like before, the mission involves the Americans taking on faceless pilots flying ambiguously identified "fifth-generation aircraft" for an unidentified rogue nation. The target is conveniently in the middle of nowhere, far enough away from any urban centers to head off distracting moralizing about civilian deaths and other collateral damage.
It's a story that very much wants to have it all ways, appealing to the broadest audience possible.
Want a daily wrap-up of all the news and commentary Salon has to offer? Subscribe to our morning newsletter, Crash Course.
But it's been a rough couple of years, and everyone's hungry for a bombastic summer flick that tickles the onions. Cruise and Kosinski target this low-key yearning by populating the movie with callbacks to the original "Top Gun," knowing how much Gen X loves its Easter Eggs and nostalgia that reminds us of our youth.
This is why nobody was expecting the opening scene of "Top Gun: Maverick" to show the title character, say, doddering around his ailing daylily farm. Cruise has a few years ahead of him before he heads the way of "The Mule," proven by the pre-movie teaser for his next great cinema conquest, 2023's "Mission ImpossibleDead Reckoning Part One."
He will be at least 60 when it comes out, and still holding the standard for refusing to age out of greatness. That fantasy doesn't belong to any party or political tribe. Claiming otherwise is simply nuts.
"Top Gun: Maverick" is now playing in theaters.
More stories like this:
Read the rest here:
No, "Top Gun" isn't an anti-woke success story, but rather a tribute to aging Tom Cruise and balls - Salon
Posted in Arizona Stem Cells
Comments Off on No, "Top Gun" isn’t an anti-woke success story, but rather a tribute to aging Tom Cruise and balls – Salon
